ReviewCurrent atherosclerosis reports2025
The Overlooked Driver of Hypertension: Mental Stress at the Crossroad of Cardiology and Psychiatry.
Review in Current atherosclerosis reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
purpose of reviewMental stress has long been overlooked in the development of hypertension. We aim to provide new insights for clinicians in managing this condition.This review aims to summarize the epidemiological characteristics, complex mechanisms, diagnostic methods, as well as both non-pharmacological and pharmacological treatment strategies for mental stress-induced hypertension. RECENT
findingsMany hypertensive patients continue to experience fluctuations in blood pressure despite being treated with multiple anti-hypertensive medications. Mental stress-induced hypertension represents a potentially reversible and often underrecognized contributor to cardiovascular risk. Timely identification allows for early, targeted intervention that addresses both hemodynamic control and the underlying psychosocial triggers. Such an approach should combine evidence-based antihypertensive therapy with structured psychological interventions, including validated non-pharmacological measures and pharmacological agents targeting anxiety or depressive symptoms. By integrating cardiovascular and mental health strategies, clinicians can improve long-term blood pressure control, enhance overall patient well-being, and reduce the incidence of adverse cardiovascular events.
Indexed as
Identifiers
41417166What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.